Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00414440
Status:
COMPLETED
Last Update Posted:
2015-01-14
First Post:
2006-12-20
Brief Title:
Efficacy Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Autosomal Dominant Polycystic Kidney Disease |
Keywords:
| Name | View |
|---|---|
| end-stage renal disease ESRD autosomal dominant polycystic kidney disease ADPKD everolimus | View |